As of January 22, 2025, 10x Genomics (TXG) has a market cap of $2.00 billion USD. According to our data, 10x Genomics is ranked No.4138 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $2.00 B |
30.23%
|
Dec 31, 2024 | $1.54 B |
-74.34%
|
Dec 29, 2023 | $5.99 B |
53.57%
|
Dec 30, 2022 | $3.90 B |
-75.54%
|
Dec 31, 2021 | $15.94 B |
5.20%
|
Dec 31, 2020 | $15.15 B |
85.70%
|
Dec 31, 2019 | $8.16 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Illumina
ILMN
|
$22.13 B |
-0.001 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$220.26 B |
-0.000 M
|
USA
|
Agilent Technologies
A
|
$43.42 B |
43.425 B
|
USA
|
Bio-Rad Laboratories
BIO
|
$9.97 B |
1.786 B
|
USA
|
Pacific Biosciences
PACB
|
$0.53 B |
-0.000 M
|
USA
|
Becton Dickinson
BDX
|
$69.32 B |
0.001 M
|
USA
|
Park Hotels & Resorts
PK
|
$2.83 B |
-0.000 M
|
USA
|
Qiagen
QGEN
|
$10.54 B |
-0.000 M
|
Netherlands
|
Danaher
DHR
|
$177.06 B |
-0.004 M
|
USA
|
Bruker
BRKR
|
$9.19 B |
0.000 M
|
USA
|
Merck KGaA
MRK.DE
|
$65.52 B |
46.041 B
|
Germany
|
Sartorius
SRT.DE
|
$16.32 B |
9.238 B
|
Germany
|
Market Cap | = | TXG Stock Price | * | TXG Shares Outstanding |
= | $16.53 | * | 0.11 B | |
= | $2.00 B |